Related Experiment Video
Updated: Aug 16, 2025

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
A rare case of Pseudomonas putida ventriculitis in intensive care unit: A case report
Mohammad Nizam Mokhtar1, Izzuddin Azaharuddin1, Farah Hanim Abdullah1
1Department of Anaesthesiology and Intensive Care, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Abstract:
Pseudomonas putida is a rare pathogen leading to nosocomial and central nervous system infections. Despite having a low virulence and being a rare organism to cause bacteremia, it can evolve into a multidrug-resistant organism and lead to mortality and morbidity in the intensive care setting. A 64-year-old male gardener was presented with extensive acute subarachnoid hemorrhage with intraventricular extension causing hydrocephalus requiring embolization and coiling following a cerebral angiogram, which showed bilateral posterior circulation aneurysm and left anterior circulation aneurysm. External ventricular drain (EVD) was inserted given the worsening hydrocephalus. During his stay in the intensive care unit (ICU), he was becoming more septic and a full septic workup including a cerebral spinal fluid culture taken from the indwelling catheter of the EVD and was found to be positive for a ceftazidime-sensitive strain of P. putida. Following the treatment with intravenous ceftazidime for 1 week and a revision of the EVD on day 32 of admission, he continued to recover well and showed an improvement in his Glasgow Coma Scale (GCS) and septic parameters. Eventually, he was able to wean off mechanical ventilation. He was discharged from ICU care to the neurosurgical ward with supplemental oxygen on day 42 of admission. It is necessary to be aware of the possibility of nosocomial P. putida infection, especially in patients with indwelling catheters, and to consider the early initiation of appropriate antibiotic regimens once detected as well as strict precautions in hygiene during the management of these patients to avoid further development of multi-drug resistant (MDR) strains.
Insights
Pseudomonas putida, a rare pathogen, can cause serious nosocomial infections in intensive care units. Early detection and appropriate antibiotics are crucial for managing these infections, especially in patients with catheters, to prevent multidrug resistance.
Area of Science:
- Infectious Diseases
- Neurocritical Care
- Medical Microbiology
Background:
- Pseudomonas putida is an opportunistic pathogen rarely associated with bacteremia and central nervous system (CNS) infections.
- Nosocomial infections, particularly in intensive care units (ICUs), pose significant risks, especially for patients with indwelling devices.
- Subarachnoid hemorrhage and subsequent hydrocephalus necessitate interventions like external ventricular drains (EVDs), increasing infection risk.
Observation:
- A 64-year-old male with subarachnoid hemorrhage and hydrocephalus developed sepsis during ICU stay.
- Cerebrospinal fluid (CSF) culture via EVD catheter revealed a ceftazidime-sensitive Pseudomonas putida infection.
- The patient required EVD revision and received intravenous ceftazidime treatment.
Findings:
- Successful treatment with ceftazidime led to clinical improvement, including better Glasgow Coma Scale (GCS) scores and resolution of septic parameters.
- The patient was successfully weaned from mechanical ventilation and discharged from ICU care.
- Pseudomonas putida, though rare, can cause severe nosocomial infections in vulnerable patients.
Implications:
- Highlights the importance of vigilance for Pseudomonas putida infections in ICU patients, particularly those with EVDs.
- Emphasizes the need for prompt diagnosis and targeted antibiotic therapy to prevent severe outcomes and multidrug resistance (MDR).
- Underscores the critical role of strict hygiene protocols in preventing the spread of nosocomial pathogens in healthcare settings.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis I: Introduction
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis IV: Nursing Management